United States Antimony에 대한 매도 수량은 투자자에게 United States Antimony의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

United States Antimony (AMEX:UAMY) 주식, 공매도 수량 보고

United States Antimony

United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has four operating segments: United States Antimony, Mexican antimony, zeolite, and Precious metals. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.

Commodities

UAMY

2024년 5월 15일 주요 뉴스: U.S. 안티모니: U.S. 안티모니(Antimony) (AMEX:UAMY)는 판매 비용 증가 감소로 인해 매출이 28% 증가한 283만 달러, 총 이익이 108% 증가한 1분기 결과를 보고했다. 

수요일 주요 광업 뉴스: U.S. 안티모니, 피드몬트 리튬, 페로글로브, 솔리타리오 리소스

United States Antimony Corporation Common Stock

United States Antimony Corp

Earnings

ABOS

ABSI

ACNT

ACTG

AENT

AGEN

AIOT

AIRG

ALIT

ALTG

AMBC

AMPS

AMTX

APEI

AREB

ARIS

ARMN

ATRA

AUTL

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

AXSM

AZTA

BHIL

BLDE

BLFS

BLTE

The Beachbody Company, Inc. Class A Common Stock

BODI

BRTX

BTMD

BTTR

BWAY

BXSL

BZFD

CAMT

CART

CATX

CAVA

CBAT

CBLL

CCLD

CGEN

CHGG

CHMI

CLSD

CNNE

CRNX

CRON

CRVS

CRWS

CVAC

CXAI

DAVA

DAVE

DRCT

DYAI

EARN

EGAN

ELMD

ETON

EVCM

EVGO

EYEN

FENG

FGEN

FIHL

FLNG

FOUR

FTCI

GENI

GENK

GMGI

GOVX

GRAL

GRDN

GROV

GRPN

GRVY

Earnings Scheduled For November 12, 2024

<p>United States Antimony Corporation ("USAC", or the "Company"), (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UAMY#NYSE">UAMY</a>), a leader in the processing of critical minerals, has announced today that it has successfully staked and recorded an additional 24 new claims totaling 3,840 acres (6 square miles) on Alaska State lands near <strong>Stibnite Creek</strong>, located in the <strong>Tok area</strong> of Alaska. This strategic move places UAMY in a known antimony-rich region along the Alaska Highway, approximately 200 miles southeast of Fairbanks. With this addition, the Company now controls a total of 93 claims totaling 14,880 acres in Alaska, most of which is either associated with antimony or other critical minerals.</p>


United States Antimony Corporation Further Expands Alaska Mining Land Ownership Position With Acquisition Of Stibnite Creek Antimony Claims; No Financial Terms Disclosed

<p>As of Aug 19, 2024, three stocks in the materials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.</p>
<p>The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. </p>
<p>Here's the latest list of major overbought players in this sector.</p>
<h3 class="wp-block-heading"><strong>Aspen Aerogels Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASPN#NYSE">ASPN</a>)</strong></h3>
<ul>
<li>On Aug. 7, Aspen Aerogels reported better-than-expected second-quarter revenue results. &#8220;This quarter&#8217;s results demonstrate the significant operating leverage of our business model as we continue to utilize a higher percentage of our current capacity and effectively execute our strategy,&#8221; commented Don Young, Aspen&#8217;s President and CEO. The company's stock gained around 35% over the past five days and has a <a href="https://www.benzinga.com/quote/ASPN">52-week high of $31.74</a>.</li>
<li><strong>RSI Value:</strong> 73.40&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li><strong>ASPN Price Action:</strong> Shares of Aspen Aerogels gained 22.6% to close at $29.92 on Friday.</li>
</ul>
<h3 class="wp-block-heading"><strong>Anglogold Ashanti PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AU#NYSE">AU</a>)</strong></h3>
<ul>
<li>On Aug. 6, AngloGold Ashanti reported a year-over-year increase in H1 financial results. &#8220;These results show the hard work that&#8217;s been done to improve the fundamentals of our business, to drive productivity benefits and manage costs to ensure we capture the benefit of stronger gold prices,&#8221; CEO Alberto Calderon said. &#8220;We expect to deliver an even stronger second-half performance.&#8221; The company's stock gained around 12% over the past month and <a href="https://www.benzinga.com/quote/AU">has a 52-week high</a> of $31.65.</li>
<li><strong>RSI Value:</strong> 70.53</li>
<li><strong>AU Price Action:</strong> Shares of Anglogold Ashanti gained 3.6% to close at $31.47 on Friday.</li>
</ul>
<h3 class="wp-block-heading"><strong>United States Antimony Corporation </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UAMY#NYSE">UAMY</a>)</h3>
<ul>
<li>On Aug. 9, the company said revenues for the first six months of 2024 increased 26%, or $1.169 million, to $5.6 million, compared to the first six months of 2023. The company's stock gained around 71% over the past month and has a <a href="https://www.benzinga.com/quote/UAMY">52-week high</a> of $0.57.</li>
<li><strong>RSI Value:</strong> 84.97</li>
<li><strong>UAMY Price Action:</strong> Shares of United States Antimony gained 11.6% to close at $0.53 on Friday.</li>
</ul>
<p>Read More: </p>
<ul>
<li><a href="https://www.benzinga.com/markets/24/08/40420521/jim-cramer-recommends-buying-clorox-ceo-has-done-remarkable-job">Jim Cramer Recommends Buying Clorox: &#8216;CEO Has Done Remarkable Job&#8217;</a></li>
</ul>


News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

ASPN

Top 3 Materials Stocks That May Collapse In Q3

United States Antimony Corporation Acquires 100% Ownership Of 97 Mining Claims And 3 Leases In Ontario's Sudbury District, Targeting Critical Minerals Cobalt, Nickel, Copper, And Bismuth Amid Canada's Billion-Dollar Plan To Boost Critical Minerals Sector

<h3 class="wp-block-heading">U.S. Antimony</h3>
<p><strong>U.S. Antimony</strong> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UAMY#AMEX">UAMY</a>) reported its first-quarter (Q1) results with revenues rising 28% to $2.83 million and a 108% increase in gross profit due to a lower rise in sales costs.&nbsp;</p>
<ol>
<li></li>
</ol>
<ul>
<li>Operating expenses increased by 183%, partly due to non-cash stock compensation and net income for Q1 was $86k.&nbsp;</li>
<li>The company ceased its Mexico operations, reduced overhead and shifted to a &#8220;Discontinued Operation.&#8221;&nbsp;</li>
<li>Cash position improved to $11.94 million and chairman and co-CEO <strong>Gary C. Evans </strong>called the quarter a turning point, emphasizing improved U.S. operations and a strong cash position.</li>
</ul>
<p><em>Also Read:</em><a href="https://www.benzinga.com/topic/mining"><em> </em></a><a href="https://www.benzinga.com/news/large-cap/24/05/38826363/anglo-american-expedites-plan-to-divest-de-beers-other-assets-after-rebuffing-bhp-takeover-bid"><em>Anglo American Expedites Plan To Divest De Beers, Other Assets After Rebuffing BHP Takeover Bid</em></a></p>
<h3 class="wp-block-heading">Piedmont Lithium</h3>
<p><strong>Piedmont Lithium</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLL#NASDAQ">PLL</a>) announced new high-grade lithium zones at North American Lithium (NAL) in Quebec, jointly owned by Piedmont (25%) and Sayona Mining Limited (75%).&nbsp;</p>
<ol start="2">
<li></li>
</ol>
<ul>
<li>The 2023 drill program suggests a potential mineral resource upgrade and mine life extension, discovering thick spodumene-bearing pegmatites beyond current operations.&nbsp;</li>
<li>NAL, which restarted production in March 2023, has consistently set record production volumes.&nbsp;</li>
<li>President and CEO <strong>Keith Phillips </strong>highlighted the potential for resource upgrades, emphasizing NAL&#8217;s strategic importance and exciting possibilities for extended mine life and increased production.</li>
</ul>
<h3 class="wp-block-heading">Ferroglobe</h3>
<p><strong>Ferroglobe </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSM#NASDAQ">GSM</a>) reported Q1 financial results with an adjusted EBITDA of $25.8 million. The company achieved a positive net cash position for the first time.&nbsp;</p>
<ol start="3">
<li></li>
</ol>
<ul>
<li>The company's gross debt hit an all-time low of $81 million. It initiated and announced quarterly cash dividends of 1.3 cents per share.&nbsp;</li>
<li>A $200 million stock buyback program over five years was also approved, pending a shareholder vote in June 2024.&nbsp;</li>
<li>French operations were fully restarted on April 1. The company is applying for a permit to expand U.S. silicon metal production and signed an MOU with Coreshell, followed by a post-quarter investment after positive lab test results.</li>
</ul>
<h3 class="wp-block-heading">Solitario Resources</h3>
<p><strong>Solitario Resources</strong> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/XPL#AMEX">XPL</a>) discovered three new high-grade gold zones – Holland, Top Dollar and Wildcat – at its Golden Crest project.&nbsp;</p>
<ol start="4">
<li></li>
</ol>
<ul>
<li>Reconnaissance sampling revealed gold values up to 57.9 grams per ton (gpt).&nbsp;</li>
<li>The zones span a four-square-kilometer area between Downpour and Sleeping Beauty targets, with 203 samples collected, including 27 samples exceeding one gpt gold.&nbsp;</li>
<li>President and CEO <strong>Chris Herald </strong>highlighted these as some of the highest-grade initial samples at Golden Crest and anticipates the upcoming drilling program starting in June.</li>
</ul>
<p><em>Now Read:</em><a href="https://www.benzinga.com/"><em> </em></a><a href="https://www.benzinga.com/news/24/05/38791907/australia-injects-374m-into-critical-minerals-exploration-weve-got-some-huge-advantages"><em>Australia Injects $374M Into Critical Minerals Exploration: &#8216;We&#8217;ve Got Some Huge Advantages&#8217;</em></a></p>
<p><strong><em>Benzinga Mining is the bridge between mining companies and retail investors. Reach out to <a href="mailto:licensing@benzinga.com">licensing@benzinga.com</a> to get connected with the Benzinga community!</em></strong></p>


US Antimony Halts Mexico Operations; Piedmont Lithium New Discoveries; Ferroglobe Sees Positive Net Cash And More: Wednesday's Top Mining Stories

<p><strong>Top Stories for March 11, 2024:</strong></p>
<p>1. <strong>United States Antimony Corporation </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UAMY#NYSE">UAMY</a>) announced the immediate discontinuation of all <a href="https://www.benzinga.com/topic/mining">operations in Latin America</a>, including the sale or closure of its U.S. Antimony de Mexico subsidiary.</p>
<p>This action will affect the company's Madero smelter and the Puerto Blanco mining facility due to their long-standing negative cash flow and lack of future profitability.&nbsp;</p>
<p>The move aims to improve cash flow for its remaining business in Thompson Falls, Montana.&nbsp;</p>
<p>The company plans to sell or lease the affected assets and has begun looking for buyers or lessees. The financial impact of these actions is currently unclear.&nbsp;</p>
<p>United States Antimony will retain its Los Juarez mining claims, which have significant exploration potential but no active operations.</p>
<p>Chairman and Co-CEO <strong>Gary C. Evans</strong> said, "Based upon a thorough review of historical financial numbers of our Mexican operations&#8230; it became painfully obvious that these operations have always<strong> </strong>been unprofitable.… Antimony continues to be a &#8216;Critical Mineral&#8217; on the U.S. Government&#8217;s Defense and Energy lists of needs. Our existing operation in Thompson Falls is profitable and continues to operate efficiently."</p>
<p><em>Also Read: <a href="https://www.benzinga.com/etfs/sector-etfs/24/03/37568022/gold-etfs-diverge-from-spot-prices-record-ninth-consecutive-month-of-outflows">Gold ETFs Diverge From Spot Prices: Record Ninth Consecutive Month Of Outflows</a></em></p>
<p>2. <strong>United States Steel Corporation</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) <a href="https://www.ussteel.com/newsroom/-/blogs/u-s-steel-makes-strategic-investment-in-pittsburgh-based-autonomous-warehousing-pioneer-freespace-robotics?_com_liferay_blogs_web_portlet_BlogsPortlet_redirect=https%3A%2F%2Fwww.ussteel.com%3A443%2Fnewsroom%3Fp_p_id%3Dcom_liferay_blogs_web_portlet_BlogsPortlet%26p_p_lifecycle%3D0%26p_p_state%3Dnormal%26p_p_mode%3Dview%26_com_liferay_blogs_web_portlet_BlogsPortlet_cur%3D1%26_com_liferay_blogs_web_portlet_BlogsPortlet_delta%3D20">invested</a> in Freespace Robotics, a Pittsburgh-based company specializing in innovative robotic storage and retrieval systems for global warehouses. </p>
<p>The company&#8217;s autonomous storage system uses robots for efficient handling and storage of goods.&nbsp;</p>
<p>Funds from U.S. Steel will be used for pilot programs, establishing a manufacturing base in the region and hiring local talent and expanding its team.&nbsp;</p>
<p>U.S. Steel's Director of Strategy and Corporate Development, <strong>Jim Cook</strong>, will also join Freespace Robotics' Board of Directors.</p>
<p>Senior Vice President and Chief Technology Officer <strong>Christian Gianni</strong> stated, "Investing in Freespace Robotics is another way we're promoting innovation while supporting the regional economy and its workforce…we&#8217;re doubling down on the region because we believe in its potential to be a force for innovation in the U.S. and beyond."</p>
<p>The details of the investment were not disclosed.</p>
<p>3. Benchmark analyst Nathan Martin maintained <strong>Ramaco Resources </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/METC#NASDAQ">METC</a>) with a Buy and <a href="https://www.benzinga.com/quote/METC/analyst-ratings">raised his price target</a> from $20 to $27.</p>
<p>4. Seaport Global analyst Martin Englert <a href="https://www.benzinga.com/quote/WS/analyst-ratings">initiated coverage</a> on <strong>Worthington Steel </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WS#NYSE">WS</a>) with a Neutral rating.</p>
<p><em>Now Read: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37569351/gold-rises-to-all-time-highs-marks-longest-winning-streak-since-july-2000-driven-by">Gold Rises To All-Time Highs: Rate Cut Anticipation Drives Longest Winning Streak Since July 2000</a></em></p>
<p><em>Image created using artificial intelligence with Midjourney.</em></p>


Price Target

Topics

Analyst Ratings

METC

US Antimony Halts Latin American Operations; US Steel Invests In Freespace Robotics And More: Monday's Top Mining Stories

<p>United States Antimony Corporation ("USAC"), (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UAMY#NYSE">UAMY</a>) announced today changes with the executive level management of the Company. These executive management changes are effective March 1, 2024.</p>
<p>Mr. John (Gus) Gustavsen has been appointed President of the Company's Antimony Division and he has relinquished his title as CEO of U.S. Antimony Corporation. The Company is continuing its operations and business activities in Thompson Falls, Montana, where Mr. Gustavsen resides. This location is the only North American producer of Antimony products, including antimony oxide, antimony metal, and antimony tri-sulfide. Antimony is used in munitions (lead hardening for bullets and primer production), flame retardants, semiconductors, and batteries. Mr. Gustavsen is considered one of the nation's leading experts in the field of Antimony.</p>
<p>The Board of Directors has asked two existing board members to serve as Co-CEOs while the company continues to streamline its business, rid itself of unprofitable operations, and pursue certain expansion efforts which may include acquisitions. The new positions are as follows:</p>
<p>Joe Bardswich - Co-CEO &amp; Director</p>
<p>Gary C. Evans - Co-CEO &amp; Chairman of the Board</p>
<p>Neither Mr. Bardswich nor Mr. Evans are receiving any cash compensation for their new roles at the Company. However, the Board has granted them time-based equity compensation, which was awarded at the Company's stock price on the grant date.</p>


Management

U.S. Antimony Announces Executive Management Changes; Mr. John (Gus) Gustavsen Appointed As President, Relinquished Title Of CEO; Board Of Directors Has Asked Two Existing Board Members To Serve As Co-CEOs, Joe Bardswich And Gary C. Evans, Effective March 1, 2024

<p><strong>Top Stories for Jan. 29, 2024:</strong></p>
<p>1. TD Cowen downgraded <strong>Piedmont Lithium Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pll#NASDAQ">PLL</a>) from Outperform <a href="https://www.benzinga.com/quote/PLL/analyst-ratings">to Market Perform.</a></p>
<p>2. President <strong>Joe Biden&#39;</strong>s economic advisors signaled a commitment <a href="https://www.benzinga.com/markets/equities/24/01/36815501/bidens-advisors-signal-labor-focus-in-nippon-steels-united-states-steel-deal-amid-election-year-">to protecting union jobs</a> and U.S. steel manufacturing, implying that <strong>U.S. Steel Corporation</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/x#NYSE">X</a>) would need to increase its support for organized labor for its $14.1 billion deal with Nippon Steel Corporation to be finalized.</p>
<p>On a related note, former Louisiana Attorney General&nbsp;<strong>Charles C.&nbsp;Foti, Jr., Esq. </strong>and the law firm of Kahn Swick &amp; Foti, LLC are investigating the proposed sale of United States Steel.</p>
<p>Under the terms of the transaction, U.S. Steel shareholders will receive $55 in cash per share, and the investigation will determine whether that deal is adequate or undervalues the company.</p>
<p>3. <strong>United States Antimony Corporation</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uamy#NYSE">UAMY</a>) appointed <strong>Jeffrey Fink</strong> as its Vice President and General Manager of its Bear River Zeolite mining operation.</p>
<p>Chairman of the Board <strong>Gary C. Evans</strong> said, &quot;Management and the Board of Directors at UAMY completed an exhaustive search over the last several months for a new general manager of our Bear River Zeolite mining operation located in Preston, Idaho. We believe this property has significant potential for increased production volumes.&quot;</p>
<p>&quot;We are very pleased to announce today that this mission has been accomplished with the hiring of Jeffrey (Jeff) Fink as our new Vice President and General Manager of BRZ&hellip;Based upon his past experience, his energetic enthusiasm, his passion for safety and profit-minded drive for continuous process manufacturing, we are anticipating substantial improvements (including product supply for our customers) at BRZ under his watch,&quot; he added.</p>
<p>4. <strong>American Battery Technology Company</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abat#NASDAQ">ABAT</a>) will participate in the Bloomberg New Energy Finance Summit in San Francisco from Jan. 30 to Jan. 31.</p>
<p>CEO <strong>Ryan Melsert</strong> will join a &quot;Can Battery Recycling Solve Supply Chain Challenges&#39;&#39; panel to discuss industry challenges, including the domestic scaling of battery recycling capacity.</p>
<p><em>Now Read:&nbsp;<a href="https://www.benzinga.com/government/24/01/36832252/short-seller-does-victory-lap-after-amazon-deal-dies-what-happened-to-irobot">Short Seller Does Victory Lap After Amazon Deal Dies &mdash; What Happened To iRobot?</a></em></p>
<p><em>Photo: Shutterstock</em></p>


Penny Stocks

Small Cap

ABAT

TD Cowen Downgrades Piedmont; Biden On US Steel Deal; American Battery At Bloomberg Summit And More

<p>The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.</p>
<p>The RSI is a momentum indicator, which compares a stock&#39;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#39;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/"> Benzinga Pro</a>.</p>
<p>Here&rsquo;s the latest list of major oversold players in this sector, having an RSI near or below 30.</p>
<h3><strong>United States Antimony Corporation </strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uamy#NYSE">UAMY</a>)</h3>
<ul>
<li>U.S. Antimony, during August, announced appointment of Gary C. Evans as Chairman of its Board of Directors. The company&rsquo;s stock has a <a href="https://www.benzinga.com/quote/UAMY"><em>52-week low of $0.24 </em></a>.</li>
<li><strong>RSI Value:</strong> 29.71</li>
<li><strong>UAMY Price Action: </strong> Shares of United States Antimony fell 2% to close at $0.2550 on Tuesday.</li>
</ul>
<h3><strong>Northern Technologies International Corporation </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ntic#NASDAQ">NTIC</a>)</h3>
<ul>
<li>Northern Technologies posted weaker-than-expected earnings for the fourth quarter. &ldquo;Fiscal 2023 marked NTIC&rsquo;s third year of consecutive record sales, despite the economic challenges growing in both Europe and China, as well as rising interest rates in the U.S. Our continued sales growth success demonstrates the increasing value we provide our global customers as well as the efficacy of our strategic focus on diversifying our products, end markets and geographies,&rdquo; said G. Patrick Lynch, President and CEO of NTIC. It <a href="https://www.benzinga.com/quote/NTIC"><em> has a 52-week low </em></a> of $10.10.</li>
<li><strong>RSI Value:</strong> 24.22</li>
<li><strong>NTIC Price Action: </strong> Shares of Northern Technologies International fell 4.2% to close at $11.21 on Tuesday.</li>
</ul>
<h3><strong>Gulf Resources, Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gure#NASDAQ">GURE</a>)</h3>
<ul>
<li>The company posted a loss for the third quarter. &ldquo;We are vigilantly monitoring events in the Middle East, recognizing that any disruptions in the Dead Sea region could suddenly alter market dynamics. Looking ahead, we envision returning to profitability in the forthcoming quarters,&rdquo; Mr. Liu Xiaobin, CEO said. The company&rsquo;s stock has a 52-week <a href="https://www.benzinga.com/quote/GURE"><em> low of $1.44.</em></a></li>
<li><strong>RSI Value:</strong> 20.59</li>
<li><strong>GURE Price Action: </strong> Shares of Gulf Resources fell 4.2% to close at $1.4650 on Tuesday.</li>
</ul>
<h3><strong>Millennium Group International Holdings Limited </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgih#NASDAQ">MGIH</a>)</h3>
<ul>
<li>The company&rsquo;s stock lost around 41% over the past month. The company&rsquo;s 52-week low is $0.89.</li>
<li><strong>RSI Value:</strong> 24.10</li>
<li><strong>MGIH Price Action: </strong> Shares of Millennium Group International fell 1.4% to close at $0.9660 on Tuesday.</li>
</ul>
<h3><strong>Sibanye Stillwater Limited </strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sbsw#NYSE">SBSW</a>)</h3>
<ul>
<li>B of A Securities, last month, downgraded Sibanye Stillwater from Neutral to Underperform. The company <a href="https://www.benzinga.com/quote/SBSW"><em> has a 52-week low </em></a> of $4.00.</li>
<li><strong>RSI Value:</strong> 24.44</li>
<li><strong>SBSW Price Action: </strong> Shares of Sibanye Stillwater fell 17.9% to close at $4.27 on Tuesday.</li>
</ul>
<p>&nbsp;</p>
<p>Read More: <a href="https://www.benzinga.com/news/earnings/23/11/35911235/deere-nvidia-and-3-stocks-to-watch-heading-into-wednesday"><em> Deere, Nvidia And 3 Stocks To Watch Heading Into Wednesday </em></a></p>


Long Ideas

GURE

MGIH

NTIC

SBSW

Top 5 Materials Stocks That May Rocket Higher In November

<p><strong>&nbsp;</strong>United States Antimony Corporation (&quot;USAC&quot;), (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UAMY#NYSE">UAMY</a>) announced today the decision of John (Gus) Gustavsen on July 28, 2023, to step down from his position as Chairman and a board member for personal reasons. Mr. Gustavsen will remain in his current position as Chief Executive Officer of the Company. Additionally, the Company announces the appointment of Gary C. Evans, effective July 29, 2023, as Chairman of its Board of Directors. Mr. Evans previously served as Lead Director of the Company. He will continue at this time to be deemed &quot;Independent.&quot;</p>


U.S. Antimony Announces Appointment Of Gary C. Evans As Chairman Of Its Board Of Directors; John Gustavsen Resigns From Board And Retains His Position As CEO

<p>&nbsp;United States Antimony Corporation (&quot;USAC&quot;), (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UAMY#NYSE">UAMY</a>) is pleased to announce the appointment of Richard (Rick) R. Isaak, age 55, as Senior Vice President and Chief Financial Officer effective today. He succeeds Kelly J. Stopher who previously served as the Company&#39;s contract Chief Financial Officer. Mr. Stopher will remain as a consultant during the transition period.</p>
<p>Rick started his career at Ernst &amp; Young as a CPA in the assurance and advisory business services area for 12 years with extensive experience with managing public company audits and SEC reporting primarily for large, multinational companies. After Ernst &amp; Young, Rick served in several senior leadership roles including CFO, Chief Accounting Officer, Controller, Treasurer, and Head of Investor Relations at four different companies over 20 years including Panera Bread Company, Heritage Home Group, and Merric Millwork and Seating, and Catholic Charities. He has a proven track record of leadership, strategic thinking, team development and execution, and business acumen which is welcomed at USAC during this period of change. Rick&#39;s broad range of experience in public accounting as well as in industry, which includes strategic planning, financial planning and analysis, operational finance, cash flow optimization, customer, supplier, and third-party management, and information technology, will complement and enhance the USAC senior leadership talent and skills.</p>
<p>Commenting on Rick Isaak&#39;s appointment today, Gary C. Evans, Lead Director, stated, &quot;Rick will be a key part of our new management team, the building process which is now in motion. His in-depth knowledge of cost accounting and SEC reporting requirements will greatly benefit USAC going forward. Rick also has a strong business sense and will be integral in our decision-making process of building, culling, and acquiring complementary businesses.&quot;</p>


USAC Announces Appointment Richard R. Isaak Appointed As Senior Vice President & Chief Financial Officer

<p>nited States Antimony Corporation (&quot;UAMY&quot;, &quot;U.S. Antimony&quot; or the &quot;Company&quot;) is pleased to announce that the Department of Defense (&quot;DOD&quot;) and the Defense Logistics Agency (&quot;DLA&quot;) have approved the third and final sample of antimony trisulfide supplied by the company. The samples were all taken from material obtained via concentrating feed from ore at the Sierra Guadalupe mines in the state of Zacatecas Mexico. The Company, in&nbsp;Q3&nbsp;of 2022, entered into a purchase agreement for the ownership of the mining concessions at the Sierra Guadalupe Mines and is currently engaged in negotiations for the surface rights. The mines were worked prior to 1970 and the approved material came from concentrate made from dump rock generated from that mining effort.</p>
<p>The Guadalupe supplied a small amount of high-grade feed for direct smelting in 2016-2018 that had an average grade of approximately&nbsp;32%&nbsp;antimony.</p>
<p><strong>SUMMARY:</strong></p>
<p>The mine, because of its predominance of sulfide ore, was acquired for the supply of ore to the Company&#39;s Puerto Blanco flotation facility for concentration followed by shipment to the Montana facilities for synthesis into purified antimony trisulfide crystal.</p>
<p>This approval means that U.S. Antimony now has the only approved North American mine source of antimony for the production and supply of antimony trisulfide to the DOD/DLA for primers in munitions.</p>


U.S. Antimony Announces Approval Received From DOD For Third & Final Antimony Trisulfide Sample From The Sierra Guadalupe Mines

<p>The Dow Jones closed higher by more than 250 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.</p>
<p>Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"><em> Benzinga&#39;s insider transactions </em></a> platform.</p>
<h2><strong>Theriva Biologics </strong></h2>
<ul>
<li><strong>The Trade:</strong> <strong> Theriva Biologics, Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tovx#NYSE">TOVX</a>) CEO and CFO Steven A Shallcross <a href="https://www.benzinga.com/sec/insider-trades/"><em> bought a total of 25,000 shares </em></a> at an average price of $0.75. To acquire these shares, it cost around $18.7 thousand.</li>
<li><strong>What&rsquo;s Happening:</strong> Theriva Biologics received a notice of allowance for its U.S. patent application 16/982,211 titled &quot;Alkaline Phosphatase Agents For Treatment Of Radiation Disorders.&quot;</li>
<li><strong>What Theriva Biologics Does:</strong> Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs.</li>
</ul>
<h2><strong>United States Antimony </strong></h2>
<ul>
<li><strong>The Trade</strong>: <strong> United States Antimony Corporation </strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uamy#NYSE">UAMY</a>) Director Lloyd Bardswich <a href="https://www.benzinga.com/quote/PSIX/analyst-ratings"><em> acquired a total of 10,000 shares </em></a> at an average price of $0.44. The insider spent around $4.4 thousand to buy those shares.</li>
<li><strong>What&rsquo;s Happening</strong>: On Nov. 21, 2022, United States Antimony&#39;s board approved a 5 million share stock buy back.</li>
<li><strong>What United States Antimony Does</strong>: United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company.</li>
</ul>
<p>Check This Out: <a href="https://www.benzinga.com/news/23/01/30522315/5-most-expensive-consumer-stocks-you-should-worry-about"><em> 5 Most Expensive Consumer Stocks You Should Worry About</em></a></p>
<h2><strong>Context Therapeutics</strong></h2>
<ul>
<li><strong>The Trade</strong>: <strong> Context Therapeutics Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cntx#NASDAQ">CNTX</a>) CEO Martin Lehr <a href="https://www.benzinga.com/sec/insider-trades/"><em> acquired a total of 6,839 shares </em></a> at an average price of $0.72. To acquire these shares, it cost around $4.9 thousand.</li>
<li><strong>What&rsquo;s Happening</strong>: Context Therapeutics and Lonza recently announced that the companies are collaborating to manufacture CTIM-76, Context&#39;s clinical development candidate.</li>
<li><strong>What Context Therapeutics Does</strong>: Context Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with cancer.</li>
</ul>
<p><em>Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here</a></em></p>
<h2><strong>Precipio</strong></h2>
<ul>
<li><strong>The Trade</strong>: <strong> Precipio, Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prpo#NASDAQ">PRPO</a>) Director Sandberg Richard <a href="https://www.benzinga.com/sec/insider-trades/"><em> acquired a total of 20,000 shares </em></a> at an average price of $0.78. The insider spent $15.53 thousand to buy those shares.</li>
<li><strong>What&rsquo;s Happening</strong>: Precipio signed another major hemescreen customer for $650k per year.</li>
<li><strong>What Precipio Does</strong>: Precipio Inc is a healthcare solutions company focused on cancer diagnostics.</li>
</ul>


Insider Trades

CNTX

PRPO

TOVX

Context Therapeutics And 3 Other Stocks Under $1 Insiders Are Aggressively Buying

<p>SEC Form 4</p>
<table border="0" cellpadding="4" cellspacing="0" style="width:100%">
<tbody>
<tr>
<td colspan="2">FORM 4</td>
<td rowspan="2">UNITED STATES SECURITIES AND EXCHANGE COMMISSION<br />
			Washington, D.C. 20549
<p>			STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP</p>
<p>			Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934<br />
			or Section 30(h) of the Investment Company Act of 1940</p></td>
<td rowspan="2">
<table border="1" style="width:100%" summary="OMB Approval Status Box">
<tbody>
<tr>
<td>OMB APPROVAL</td>
</tr>
<tr>
<td>
<table border="0" style="width:100%" summary="OMB Interior Box">
<tbody>
<tr>
<td colspan="3">OMB Number:</td>
<td>3235-0287</td>
</tr>
<tr>
<td colspan="4">Estimated average burden</td>
</tr>
<tr>
<td colspan="3">hours per response:</td>
<td>0.5</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td>
<table border="1" cellpadding="0" cellspacing="0" style="width:100%">
<tbody>
<tr>
<td>&nbsp;&nbsp;</td>
</tr>
</tbody>
</table>
</td>
<td>Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.&nbsp;<em>See</em>&nbsp;Instruction 1(b).</td>
</tr>
</tbody>
</table>
<table border="1" cellpadding="4" cellspacing="0" style="width:100%">
<tbody>
<tr>
<td rowspan="3">1. Name and Address of Reporting Person&#x2A;
<table border="0" style="width:100%">
<tbody>
<tr>
<td><a href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001191410">EVANS GARY C</a></td>
</tr>
</tbody>
</table>
<hr />
<table border="0" style="width:100%">
<tbody>
<tr>
<td>(Last)</td>
<td>(First)</td>
<td>(Middle)</td>
</tr>
</tbody>
</table>
<table border="0" style="width:100%">
<tbody>
<tr>
<td>PO BOX 540308</td>
</tr>
<tr>
<td>&nbsp;</td>
</tr>
</tbody>
</table>
<hr />(Street)
<table border="0" style="width:100%">
<tbody>
<tr>
<td>DALLAS</td>
<td>TX</td>
<td>75354</td>
</tr>
</tbody>
</table>
<hr />
<table border="0" style="width:100%">
<tbody>
<tr>
<td>(City)</td>
<td>(State)</td>
<td>(Zip)</td>
</tr>
</tbody>
</table>
</td>
<td>2. Issuer Name&nbsp;<strong>and</strong>&nbsp;Ticker or Trading Symbol<br />
			<a href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0000101538">UNITED STATES ANTIMONY CORP</a>&nbsp;[&nbsp;UAMY&nbsp;]</td>
<td rowspan="2">5. Relationship of Reporting Person(s) to Issuer<br />
			(Check all applicable)
<table border="0" style="width:100%">
<tbody>
<tr>
<td>X</td>
<td>Director</td>
<td>&nbsp;</td>
<td>10%&nbsp;Owner</td>
</tr>
<tr>
<td>&nbsp;</td>
<td>Officer (give title below)</td>
<td>&nbsp;</td>
<td>Other (specify below)</td>
</tr>
<tr>
<td colspan="4">&nbsp;</td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td>3. Date of Earliest Transaction (Month/Day/Year)<br />
			12/07/2022</td>
</tr>
<tr>
<td>4. If Amendment, Date of Original Filed (Month/Day/Year)</td>
<td>6. Individual or Joint/Group Filing (Check Applicable Line)
<table border="0" style="width:100%">
<tbody>
<tr>
<td>X</td>
<td>Form filed by One Reporting Person</td>
</tr>
<tr>
<td>&nbsp;</td>
<td>Form filed by More than One Reporting Person</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
<table border="1" cellpadding="4" cellspacing="0" style="width:100%">
<thead>
<tr>
<th colspan="11"><strong>Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned</strong></th>
</tr>
<tr>
<th rowspan="2">1. Title of Security (Instr. 3)</th>
<th rowspan="2">2. Transaction Date (Month/Day/Year)</th>
<th rowspan="2">2A. Deemed Execution Date, if any (Month/Day/Year)</th>
<th colspan="2">3. Transaction Code (Instr. 8)</th>
<th colspan="3">4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)</th>
<th rowspan="2">5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)</th>
<th rowspan="2">6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)</th>
<th rowspan="2">7. Nature of Indirect Beneficial Ownership (Instr. 4)</th>
</tr>
<tr>
<th>Code</th>
<th>V</th>
<th>Amount</th>
<th>(A) or (D)</th>
<th>Price</th>
</tr>
</thead>
<tbody>
<tr>
<td>UAMY - Common Stock</td>
<td>12/07/2022</td>
<td>12/07/2022</td>
<td>P</td>
<td>&nbsp;</td>
<td>251,281</td>
<td>A</td>
<td>$0.4</td>
<td>291,281</td>
<td>D</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>UAMY - Common Stock</td>
<td>12/08/2022</td>
<td>12/08/2022</td>
<td>P</td>
<td>&nbsp;</td>
<td>51,653</td>
<td>A</td>
<td>$0.41</td>
<td>342,934</td>
<td>D</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>UAMY - Common Stock</td>
<td>12/09/2022</td>
<td>12/09/2022</td>
<td>P</td>
<td>&nbsp;</td>
<td>65,902</td>
<td>A</td>
<td>$0.42</td>
<td>408,836</td>
<td>D</td>
<td>&nbsp;</td>
</tr>
</tbody>
</table>
<table border="1" cellpadding="4" cellspacing="0" style="width:100%">
<thead>
<tr>
<th colspan="16"><strong>Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned</strong><br />
			<strong>(e.g., puts, calls, warrants, options, convertible securities)</strong></th>
</tr>
<tr>
<th rowspan="2">1. Title of Derivative Security (Instr. 3)</th>
<th rowspan="2">2. Conversion or Exercise Price of Derivative Security</th>
<th rowspan="2">3. Transaction Date (Month/Day/Year)</th>
<th rowspan="2">3A. Deemed Execution Date, if any (Month/Day/Year)</th>
<th colspan="2">4. Transaction Code (Instr. 8)</th>
<th colspan="2">5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)</th>
<th colspan="2">6. Date Exercisable and Expiration Date (Month/Day/Year)</th>
<th colspan="2">7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)</th>
<th rowspan="2">8. Price of Derivative Security (Instr. 5)</th>
<th rowspan="2">9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)</th>
<th rowspan="2">10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)</th>
<th rowspan="2">11. Nature of Indirect Beneficial Ownership (Instr. 4)</th>
</tr>
<tr>
<th>Code</th>
<th>V</th>
<th>(A)</th>
<th>(D)</th>
<th>Date Exercisable</th>
<th>Expiration Date</th>
<th>Title</th>
<th>Amount or Number of Shares</th>
</tr>
</thead>
</table>
<table border="0" style="width:100%">
<tbody>
<tr>
<td><strong>Explanation of Responses:</strong></td>
</tr>
</tbody>
</table>
<table border="0" style="width:100%">
<tbody>
<tr>
<td>&nbsp;</td>
<td>/s/ Gary C. Evans</td>
<td>12/12/2022</td>
</tr>
<tr>
<td>&nbsp;</td>
<td>&#x2A;&#x2A; Signature of Reporting Person</td>
<td>Date</td>
</tr>
<tr>
<td colspan="3">Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.</td>
</tr>
<tr>
<td colspan="3">&#x2A; If the form is filed by more than one reporting person,&nbsp;<em>see</em>&nbsp;Instruction 4 (b)(v).</td>
</tr>
<tr>
<td colspan="3">&#x2A;&#x2A; Intentional misstatements or omissions of facts constitute Federal Criminal Violations&nbsp;<em>See</em>&nbsp;18 U.S.C. 1001 and 15 U.S.C. 78ff(a).</td>
</tr>
<tr>
<td colspan="3">Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,&nbsp;<em>see</em>&nbsp;Instruction 6 for procedure.</td>
</tr>
<tr>
<td colspan="3"><strong>Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.</strong></td>
</tr>
</tbody>
</table>


United States Antimony Corp. Form 4 Filing Shows Director Gary C. Evans Buys 368,836 Shares At An Average Price Of $0.40

Buybacks

On November 21, 2022 United States Antimony's Board Of Directors Approved A 5M Share Stock Buy Back

Options

SONN

SOUN

STOK

STRC

STTK

TCDA

TSLA

TTCF

TVTX

TYDE

UPWK

VCSA

VINC

VLTA

VRAX

VYNT

WISA

WKSP

WORX

WTER

XPON

Stocks That Hit 52-Week Lows On Tuesday

THCH

TNYA

TRKA

TRMB

TRUE

TSAT

TTEC

TUEM

TWKS

UAVS

UPLD

VBLT

VEDU

VEEE

VIOT

VIRI

VJET

VNTR

VRNS

VSTM

VVPR

VXRT

WILC

WIMI

WOOF

WPRT

XXII

YOSH

ZEPP

ZEST

ZIMV

ZKIN

Stocks That Hit 52-Week Lows On Monday

<h3><strong>Gainers</strong></h3>
<ul>
<li><strong>Rail Vision Ltd.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvsn#NASDAQ">RVSN</a>) shares rose 38.5% to $1.87 in pre-market trading after gaining around 5% on Tuesday.</li>
<li><strong>Brickell Biotech, Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bbi#NASDAQ">BBI</a>) rose 29% to $0.2999 in pre-market trading after the company announced the sale of sofpironium bromide to Botanix Pharmaceuticals for $9 million in upfront and potential near-term regulatory milestone payments. The company is also eligible to receive additional success-based regulatory and sales milestone payments of up to $168 million.</li>
<li><strong>Aclarion, Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acon#NASDAQ">ACON</a>) rose 28.5% to $2.21 in pre-market trading after declining over 5% on Tuesday. The company had its IPO on April 22.</li>
<li><strong>Livent Corporation </strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lthm#NYSE">LTHM</a>) rose 23.1% to $26.98 in pre-market trading after the company reported better-than-expected Q1 results and raised FY22 guidance.</li>
<li><strong>Sharps Technology, Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stss#NASDAQ">STSS</a>) rose 20.3% to $1.54 in pre-market trading after climbing around 6% on Tuesday.</li>
<li><strong>United States Antimony Corporation</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/uamy#NASDAQ">UAMY</a>) rose 16.5% to $0.48 in pre-market trading.</li>
<li><strong>CASI Pharmaceuticals, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/casi#NASDAQ">CASI</a>) rose 15% to $0.49 in pre-market trading.</li>
<li><strong>Senmiao Technology Limited</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aihs#NASDAQ">AIHS</a>) rose 12.3% to $1.27 in pre-market trading.</li>
<li><strong>Amesite Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amst#NASDAQ">AMST</a>) shares rose 10.7% to $0.7096 in pre-market trading after declining over 6% on Tuesday.</li>
<li><strong>Alaunos Therapeutics, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcrt#NASDAQ">TCRT</a>) rose 9.9% to $0.61 in pre-market trading after jumping around 13% on Tuesday.</li>
<li><strong>Expion360 Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xpon#NASDAQ">XPON</a>) rose 9.7% to $3.96 in pre-market trading. Expion360 secured $300,000 line of credit from GM Financial to support expansion of national sales and distribution channels.</li>
<li><strong>CNS Pharmaceuticals, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnsp#NASDAQ">CNSP</a>) rose 8.6% to $0.38 in pre-market trading.</li>
<li><strong>The Scotts Miracle-Gro Company</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smg#NYSE">SMG</a>) rose 7.6% to $114.00 in pre-market trading. Scotts Miracle-Gro announced record second-quarter sales in its U.S. consumer segment driven by continued support from its major retail partners.</li>
<li><strong>Starbucks Corporation</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbux#NASDAQ">SBUX</a>) rose 6.4% to $79.10 in pre-market trading as the company reported second-quarter revenue of $7.64 billion, which was up 15% year-over-year. The quarterly revenue was a second-quarter record for the company and came in ahead of a consensus estimate of $7.6 billion.</li>
<li><strong>Advanced Micro Devices, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amd#NASDAQ">AMD</a>) shares rose 6% to $96.60 in pre-market trading after the company reported better-than-expected Q1 adjusted EPS and sales results and raised FY22 sales guidance.</li>
</ul>
<p>
<em>Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>.</em></p>
<h3><strong>Losers</strong></h3>
<ul>
<li><strong>Lyft, Inc</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyft#NASDAQ">LYFT</a>) shares fell 27.2% to $22.40 in pre-market trading. Lyft reported a narrower loss for its first quarter, while sales topped estimates. However, the company issued a weak outlook for the second quarter.</li>
<li><strong>Herbalife Nutrition Ltd.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hlf#NYSE">HLF</a>) shares fell 15.6% to $23.25 in pre-market trading after the company reported a decline in Q1 EPS results.</li>
<li><strong>Akamai Technologies, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akam#NASDAQ">AKAM</a>) fell 13.9% to $98.02 in pre-market trading after the company reported worse-than-expected Q1 results.</li>
<li><strong>Blue Water Vaccines, Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bwv#NASDAQ">BWV</a>) fell 13.5% to $5.58 in pre-market trading. Blue Water Vaccines S-1 showed registration for 2.4 million share common stock offering via selling shareholders.</li>
<li><strong>IonQ, Inc. </strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ionq#NYSE">IONQ</a>) shares fell 13.5% to $6.18 in pre-market trading. IonQ shares dropped 9% on Tuesday following a short report by Scorpion Capital.</li>
<li><strong>XORTX Therapeutics Inc. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xrtx#NASDAQ">XRTX</a>) fell 10.9% to $1.63 in pre-market trading. XORTX Therapeutics shares jumped 59% on Tuesday after the company announced that dosing of human subjects has been initiated in the XRX-OXY-101 bridging pharmacokinetics study.</li>
<li><strong>Revolve Group, Inc.</strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rvlv#NYSE">RVLV</a>) fell 9.9% to $39.20 in pre-market trading after the company reported Q1 earnings results.</li>
<li><strong>Swvl Holdings Corp. </strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swvl#NASDAQ">SWVL</a>) fell 8.5% to $6.62 in pre-market trading after dipping 17% on Tuesday.</li>
<li><strong>Sonoma Pharmaceuticals, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snoa#NASDAQ">SNOA</a>) shares fell 8.3% to $3.21 in pre-market trading. Sonoma Pharmaceuticals shares jumped around 32% on Tuesday after the company and its partner MicroSafe Group DMCC received EPA approval for Nanocyn as a hospital-grade disinfectant.</li>
<li><strong>Redbox Entertainment Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdbx#NASDAQ">RDBX</a>) fell 7.6% to $6.12 in pre-market trading after dipping 22% on Tuesday.</li>
<li><strong>Ouster, Inc. </strong> (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/oust#NYSE">OUST</a>) fell 6.3% to $3.25 in pre-market trading after the company reported worse-than-expected Q1 results.</li>
<li><strong>Match Group, Inc.</strong> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtch#NASDAQ">MTCH</a>) fell 6.3% to $74.05 in pre-market trading after the company reported Q1 earnings results and issued Q2 sales guidance below analyst estimates.</li>
</ul>


Movers

ACON

27 Stocks Moving in Wednesday's Pre-Market Session

Comments

United States Antimony

매도 수량

United States Antimony (AMEX:UAMY) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌